塑造病毒免疫疗法,以致癌症向免疫细胞死亡
Anastasia S Isaeva1,2, Adriana D Trujillo Yeriomenko1, Esther Idota1
1Molecular Virology laboratory, First Moscow State Medical University (Sechenov University), Moscow, Russia.
Frontiers in oncology
|July 23, 2025
概括
瘤解毒病毒 (OVs) 是为了破坏癌细胞并刺激抗瘤免疫力而设计的. 基因改造可以提高OV的特异性和有效性,用于下一代癌症免疫疗法.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 基因治疗 基因治疗
背景情况:
- 瘤病毒 (OV) 选择性地向和破坏癌细胞,为下一代癌症治疗提供了一个有希望的途径.
- 卵巢病毒诱导免疫细胞死亡 (ICD),启动癌症免疫循环 (CIC) 激活和重塑抗癌免疫力.
- 卵巢病毒的基因工程,包括添加癌细胞特异性结合剂和免疫刺激分子,增强免疫反应,提高病毒治疗的安全性和特异性.
研究的目的:
- 为提供有关型病毒免疫疗法的最新审查.
- 突出病毒在调节瘤免疫微环境中的适应性,以加强抗癌治疗.
- 讨论改善OV瘤特异性和安全性的策略.
主要方法:
- 在PubMed上进行了文献搜索,使用与瘤病毒,免疫疗法,病毒疗法,病毒载体和基因疗法相关的术语.
- 获取的文章包括研究论文,元分析和系统评论,没有语言限制.
主要成果:
- 目前的战略重点是通过各种生化和遗传修饰来提高OV瘤的特异性和安全性.
- 讨论的方法包括转导向 (例如,异型切换,伪型) 和非转导修改 (例如,miRNA,光遗传学).
- 该审查审查了ICD和病毒修饰的机制,促进癌细胞死亡和调节抗癌免疫力.
结论:
- 由型病毒诱导的免疫性细胞死亡 (ICD) 对于强大的抗癌免疫力至关重要.
- 用免疫刺激分子对卵巢细胞的基因工程增强了治疗潜力,安全性和稳定性.
- 修改,比如删除抑制亡的病毒基因可以促进ICD,但协同效应因癌症类型而异.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines
516
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
516
Cytotoxic T Cells-mediated Immune Response
2.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.2K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Immune Response Against Viral Pathogens
928
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
928


